Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancy - Top-Institutions - MDSpire

Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancy

  • By

  • Hardeep Singh Kalsi

  • Kristofer Linton-Reid

  • Changhyun Kim

  • Mitchell Chen

  • Victoria Crowe

  • Esubalew Alemu

  • Samir Mahboobani

  • David Gibeon

  • Alexander Procter

  • Mohsen Hajhosseiny

  • Cara Owens

  • Emily C. Bartlett

  • Nuria Porta

  • Thesha Thavaraja

  • Simon Doran

  • Anand Devaraj

  • Bhupinder Sharma

  • Arjun Nair

  • Eric O. Aboagye

  • Richard W. Lee

  • May 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    NHS institutions
    NHS institutions

    London, England

    Key Differentiators

    • Oncology

  • #2

    UK Stereotactic Ablative Radiotherapy Consortium
    UK Stereotactic Ablative Radiotherapy Consortium

    London, England

    Key Differentiators

    • Radiotherapy
    • Oncology

  • #3

    North Estonia Medical Centre (NEMC) Foundation
    North Estonia Medical Centre (NEMC) Foundation

    Tallinn, Estonia

    Key Differentiators

    • Oncology
    • Radiology

  • #4

    Stanford NSCLC Radiogenomics
    Stanford NSCLC Radiogenomics

    Stanford, California

    Key Differentiators

    • Oncology
    • Genomics

  • #5

    Brock University
    Brock University

    St. Catharines, Ontario

    Key Differentiators

    • Oncology
    • Biostatistics

Original Source(s)

Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancy

  • by Hardeep Singh Kalsi, Kristofer Linton-Reid, Changhyun Kim, Mitchell Chen, Victoria Crowe, Esubalew Alemu, Samir Mahboobani, David Gibeon, Alexander Procter, Mohsen Hajhosseiny, Cara Owens, Emily C. Bartlett, Nuria Porta, Thesha Thavaraja, Simon Doran, Anand Devaraj, Bhupinder Sharma, Arjun Nair, Eric O. Aboagye, Richard W. Lee

  • May 6, 2026

Related Content

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report